Navigation Links
BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
Date:11/5/2009

each respective quarter. Research and development expenses include employee-related expenses, costs of materials, lab expenses, facility costs and overhead.

General and administrative expenses for the third quarter ended September 30, 2009 totaled $1.2 million, compared to $0.9 million for the same period in 2008. The increase in general and administrative expenses was primarily due to outside consulting expenses, directors' fees, legal fees and the Company incurring certain facility costs which were previously reimbursable under its Transition Services Agreement with DFB Biotech, which expired in October 2008.

As of September 30, 2009, the Company held cash, cash equivalents and short-term investments of $9.3 million.

Nine Months Ended September 30, 2009 and 2008

The Company reported a net loss of $1.4 million for the nine months ended September 30, 2009, or ($0.23) per basic and diluted common share, compared to a net loss of $1.5 million, or ($0.25) per basic and diluted common share, for the same period in 2008.

Revenue for the nine months ended September 30, 2009 was $2.4 million, compared to $1.2 million for the same period in 2008. The increase in revenue was due to earn-out payments triggered by certain net sales levels of topical collagenase under the earn-out payment provision of the Company's Asset Purchase Agreement with DFB Biotech and a milestone payment received and recognized from Auxilium Pharmaceuticals, Inc.

Third Quarter Corporate Highlights

  • In its September 3, 2009 edition, The New England Journal of Medicine published data from the pivotal CORD I Phase III clinical trial of XIAFLEX for the treatment of Dupuytren's disease, a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers, in an article entitled "Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture." The article descr
    '/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
2. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
3. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
4. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
5. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
6. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
7. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
8. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
9. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
10. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
11. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...Belfast are developing new sensors to detect chemi...e fight against the threat of terrorist attacks. ,..., an individual or crime scene to gather a sample ...at can detect the presence of chemicals within sec...be made in response to terrorist threats. , The...
(Date:11/18/2009)...in data analysis combined with Bio-Rad,s Biote...rricula provide state-of-the-art solutions to biot...18 Vernier Software & Technolo...sensors, and software and Bio-Rad Laboratories, In...f life science research and clinical diagnostics p...
(Date:11/18/2009)...sex, U.K. and CLEVELAND, Nov. 18 T...iness and premier provider of diagnostic systems a...has expanded its East Grinstead, U.K., manufacturi...ncreasing global demand for its Sensititre® p...testing. The expanded facility has been fully vali...
(Date:11/18/2009).../PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE...velopment company that identifies and advances a d...cts at various stages of development, announced th...e presented today in a poster at the 2009 AACR-NCI...onference in Boston, Massachusetts. The reported r...
Breaking Biology Technology:New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...onics,Corporation, (Pink Sheets: BIEL), announced ...e, has signed an agreement for the distribution of... on October 10th. TSS Medical joins the growing l...erapy. BioElectronics has signed agreements in pla...Singapore, Malaysia, Turkey,Columbia, Canada, the ...
...tope of CD44 found in breast colon, and ...23 /PRNewswire-FirstCall/ - ARIUS Research Inc., (... developing the next wave of,antibody therapeutics...m,its CD44 Cancer Stem Cell program has successful...own good efficacy in animal models. ARIUS,program ...
...Highlight the Global Pandemic of Unsafe Abortion a.... Expanding access to safe abortion around the wo...Safe Abortion Conference beginning today in,London...ly 800 public,health experts, government represent...e world convened to build momentum around reducing...
Other Biology Technology:BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy 2ARIUS announces cancer stem cell antibody program successfully completes first toxicology study 2ARIUS announces cancer stem cell antibody program successfully completes first toxicology study 3Ground-Breaking Conference Takes on Abortion 2
(Date:11/19/2009)...T. Ming Chu Professor of Biochemistry and Molecula...g how regulatory proteins control the production o...king with collaborators including Drs. Mitchell We...adelphia, they focused specifically on the complex...s). These cells contain large amounts of hemoglobi...
(Date:11/19/2009)...entified thousands of diverse genes in genetically...es may allow breeders and researchers to use this ... create new varieties that were not easily possibl...Science , the researchers, whose senior and first ...ap of haplotypes sets of closely linked gene vari...
(Date:11/19/2009)... by scientists at The Scripps Research Institute h...one long associated with metabolism and metabolic ...e. While much research has been conducted on insul...irst time the hormone has been connected to the fu...he paper was published recently in an advance, onl...
Breaking Biology News(10 mins):New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5New map of variation in maize genetics holds promise for developing new varieties 2Scripps research scientists find new link between insulin and core body temperature 2Scripps research scientists find new link between insulin and core body temperature 3Scripps research scientists find new link between insulin and core body temperature 4Fresh Blood Boosts Survival in Trauma Patients 58799 1Fresh Blood Boosts Survival in Trauma Patients 58799 2APWU Health Plan Announces New Benefits and Premiums for 2010 58795 1Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 1Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 2Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 3Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 4
... researchers watched patiently as a few computer-s... than 15,000 slightly different shapes. In real ti...ond. In the end, however, this suspended animation...l new drug target to fight drug-resistant AIDS. ,... made the discovery while studying how one rare st...
...tified a key component of the mechanism spermatozo... steady swimming undulation to the whip-cracking s...ns a new research pathway that the researchers sai...f male infertility and design new contraceptives t...they said, the exquisitely delicate analytical tec...
...searchers have developed an anti-microbial treatme..., Already, the treatment has helped heal Spirit, a... and Gasper, a beluga whale at the Georgia Aquariu... application for the technology, which they,re cur...distinguished research scientist in the department...
Other Biology News:Major WHO study concludes calcium supplements can reduce complications during pregnancy 2Major WHO study concludes calcium supplements can reduce complications during pregnancy 3Major WHO study concludes calcium supplements can reduce complications during pregnancy 4Major WHO study concludes calcium supplements can reduce complications during pregnancy 5How sperm crack the whip 2How sperm crack the whip 3New antimicrobial compound adheres to skin to promote healing 2
RNase Inhibitor from Applied Biosystems
... nucleic acids ,The GC-RICH PCR System, a blend...se, powers through templates that are difficult or...other blends of polymerases. The enhanced processi...n Solution combine to deliver superior performance...
...ed cell lines in combination with the correspondin...arameters. Nucleofector Kits are only functional i...erent cell lines can be transfected with this kit....e given in brackets in percent (Efficiency [%] / v...
...her UV irradiation and antimicrobial stainless ste... contamination! Quickly inactivate DNA between ex...ith antimicrobial coated stainless steel Deconta...built-in 30-minute timer UVP's Sterilizing UV PC...
Biology Products: